Bioinformatics, Clinical Pharmacology and Virus

In Silico Modeling Unveils a New Era in Rare Disease Drug Development

The Premier Consulting Blog

JUNE 18, 2023

Figure 1: Comparison of Clinical Trial Designs The Prelude to Applying In Silico Trials for Rare Diseases In silico clinical trials have been recognized by the FDA as useful tools in advancing personalized treatment and streamlining randomized controlled trials. BMC Bioinformatics 2020, 21(Suppl 17):527 [link]

Drug Development

Drug Development Disease Clinical Trials Drugs

Drug Discovery Digest

In Silico Modeling Unveils a New Era in Rare Disease Drug Development

Webinars

Stay Connected